MET and non-small cell lung carcinoma: The radioactivity in H1993 tumor was higher than that in A549, and the uptake of H1993 tumor can be repressed by high doses of crizotinib, confirming 18F‐FPC as an optimal candidate for PET scansions of c‐Met‐positive NSCLC tumor.